Providers

Provider Resource Center

Research

Ketamine as a Dual Treatment for Depression and Alcohol Dependence: A Groundbreaking Study

This study investigates ketamine's effectiveness in simultaneously addressing major depressive episodes and alcohol dependence. By administering a single dose of ketamine, researchers aim to observe a rapid and sustained reduction in depressive symptoms, assessed by the Hamilton Depression Rating Scale, in subjects with these co-occurring conditions. The study also emphasizes ketamine's safety and minimal adverse effects in this specific patient group. Conducted as a double-blind, randomized, placebo-controlled crossover trial, it seeks to unveil potential advancements in treating these often co-occurring and challenging conditions, possibly reshaping clinical approaches for patients struggling with both depression and alcohol dependence.

Financial Services

Manage your account or make a payment.

Disclaimers

Financing Disclaimer: $325/month for Uplift Momentum Protocol™ (medical procedure), financed over 12 months with a total cost of $3,900, 0% interest. Approval based on internal criteria, including bank account history and a soft credit pull. Payments are auto-withdrawn monthly . Subject to $25 late fee for missed payments and other terms. Cancellation within 3 days of agreement allowed. Governed by California law and AAA arbitration rules. View Terms & Conditions

Important Medical Disclaimers

Individuals showcased on KetamineUplift.com are actors, the content is not reflective of their thoughts, views, or perspectives.

Patients

Home
Science
Experience
Program
About
FAQ's
Financial Services
Contact

Providers

Provider Home
Practice Info
Resources
Research
Patient Referrals
Schedule Tour

Get in touch

(310) 280-4440
care@ketamineuplift.com

4640 Admiralty Way
Suite 718A
Marina del Rey, CA 90292

Directions

© 2024 Ketamine Uplift | Terms of Service | Privacy Policy